Safety and Efficacy of ANX-042 in Human Cardiorenal Syndrome

NCT03019653 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure
Cardiorenal Disease
Renal Disfunction

Interventions

DRUG: ANX-042
DRUG: Placebo

Sponsor

Mayo Clinic

Collaborators

[object Object]
[object Object]